0000000001309430

AUTHOR

Daniel Von Der Heiden

showing 3 related works from this author

Asymmetric [N–I–N]+halonium complexes in solution?

2020

Assessment of the solution equilibria of [bis(pyridine)iodine(I)]+ complexes by ESI-MS and NMR reveals the preference of iodine(I) to form complexes with a more basic pyridine. Mixtures of symmetric [bis(pyridine)iodine(I)]+ complexes undergo statistical ligand exchange, with a predominant entropic driving force favoring asymmetric systems. The influence of ligand basicity, concentration, temperature, and ligand composition is evaluated. Our findings are expected to facilitate the investigations, and the supramolecular and synthetic applications of halonium ions’ halogen bonds. peerReviewed

inorganic chemicals2019-20 coronavirus outbreakliuoksetLigandMetals and AlloysSupramolecular chemistrychemistry.chemical_elementliganditkompleksiyhdisteetGeneral ChemistryIodineMedicinal chemistryCatalysisSurfaces Coatings and FilmsElectronic Optical and Magnetic MaterialsIonjodichemistry.chemical_compoundchemistryPyridineHalogenMaterials ChemistryCeramics and CompositesHalonium ionChemical Communications
researchProduct

Secoiridoids and Iridoids from Morinda asteroscepa

2020

The new 2,3-secoiridoids morisecoiridoic acids A (1) and B (2), the new iridoid 8-acetoxyepishanzilactone (3), and four additional known iridoids (4–7) were isolated from the leaf and stem bark methanol extracts of Morinda asteroscepa using chromatographic methods. The structure of shanzilactone (4) was revised. The purified metabolites were identified using NMR spectroscopic and mass spectrometric techniques, with the absolute configuration of 1 having been established by single-crystal X-ray diffraction analysis. The crude leaf extract (10 μg/mL) and compounds 1–3 and 5 (10 μM) showed mild antiplasmodial activities against the chloroquine-sensitive malaria parasite Plasmodium falciparum (…

Iridoidmedicine.drug_classMetabolitePharmaceutical Science01 natural sciencesAnalytical Chemistrychemistry.chemical_compoundDrug Discoverymedicineorgaaniset yhdisteetnuclear magnetic resonance spectroscopyPharmacologyantimikrobiset yhdisteetStem barkOrganisk kemiChromatographybiology010405 organic chemistrymatarakasvitOrganic ChemistryAbsolute configurationBiochemistry and Molecular BiologyalkylsPlasmodium falciparumbiology.organism_classificationluonnonaineetMass spectrometric0104 chemical sciences3. Good health010404 medicinal & biomolecular chemistryComplementary and alternative medicinechemistryMorindachemical structureMolecular Medicineorganic compoundsBiokemi och molekylärbiologi
researchProduct

CCDC 1963302: Experimental Crystal Structure Determination

2020

Related Article: Linda Zandi, Marco Makungu, Joan J. E. Munissi, Sandra Duffy, Rakesh Puttreddy, Daniel von der Heiden, Kari Rissanen, Vicky M. Avery, Stephen S. Nyandoro, Máté Erdélyi|2020|J.Nat.Prod.|83|2641|doi:10.1021/acs.jnatprod.0c00447

Space GroupCrystallographyCrystal SystemCrystal Structure24-dihydroxy-5-(3-hydroxy-1-methoxy-1-oxopropan-2-yl)-2-methylcyclopentane-1-carboxylic acidCell ParametersExperimental 3D Coordinates
researchProduct